Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

3.390 -0.150 (-4.24%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AtaiBeckley Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
29 30 Next >
News headline image
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event ↗
The Benzinga Psychedelics Capital Conference (PCC) is rapidly becoming the place to be for all those interested or involved in the space. In addition to being the place where deals are done, you'll... 
Via Benzinga
News headline image
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 9, 2023 ↗
 
Via Benzinga
News headline image
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for ATAI Life Sciences ↗
 
Via Benzinga
News headline image
Atai Layoffs 2023: What to Know About the Latest ATAI Job Cuts ↗
Atai Life Sciences has just announced 30% job cuts. Here's how investors should be interpreting the Atai layoffs as ATAI stock rises. 
Via InvestorPlace
News headline image
Atai Life Sciences: Long On Money; Short On Success ↗
A review of Atai Life Sciences' latest quarterly financials, the history of its stock price performance, and the price forecasts for the stock over the next 12 months. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From March 6, 2023 ↗
 
Via Benzinga
News headline image
Atai Update: Ketamine Trials Are Ongoing, Company Cuts 30% Workforce ↗
The clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) founded in 2018 shared updates on the two clinical trials as well as its plan to streamline its workforce with significant... 
Via Benzinga
News headline image
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets ↗
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.   
Via Benzinga
News headline image
atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates
From atai Life Sciences
Via GlobeNewswire
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 2, 2023 ↗
 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
atai Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference
From atai Life Sciences
Via GlobeNewswire
News headline image
Psychedelic Stock Gainers And Losers From February 28, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 27, 2023 ↗
 
Via Benzinga
News headline image
"Rags-To-Riches" Portfolio Outpacing S&P 500 By 2-To-1 Margin ↗
The 
Via Talk Markets
News headline image
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD ↗
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage... 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From February 24, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 23, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 22, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 21, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 20, 2023 ↗
 
Via Benzinga
News headline image
"Rags-To-Riches" Portfolio Underperforming YTD ↗
The munKNEE 
Via Talk Markets
News headline image
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD ↗
A look at the performance of the six largest psychedelic stocks by market capitalization. 
Via Talk Markets
News headline image
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 15, 2023 ↗
 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.